Blog

Jennifer Bires: Latest AI developments in mental health

Jennifer Bires/LinkedIn

Nov 7, 2024, 15:51

Jennifer Bires: Latest AI developments in mental health

“I can see so much potential for these models specifically in the world of mental health of cancer patients.

Thanks for your leadership here, Jennifer Bires, Kyle Bonesteel.

Keep the good content coming, I am following with great interest.

Who wants to author an AI Applications in Oncology Patient Mental Health review paper for AI in Precision Oncology?

I’d love to publish that manuscript in our February issue.”

Quoting post:

“Imagine a world where AI bridges critical mental health gaps, making care more accessible and compassionate.

In the mental health field, one challenge stands out: staffing shortages. But what if technology could offer relief?

Some of the advancements in AI can actually bring a more human touch to our work.

AI is transforming our approach by:

• Relieving documentation burdens – allowing us to focus more on patient interactions.
• Expanding access to care – reaching underserved communities here and abroad.
• Improving patient outcomes – through real-time insights and personalized care.

AI doesn’t replace human compassion; it amplifies it. By reducing repetitive tasks and creating efficiencies, we have more time to engage deeply with the people we serve. It’s a game-changer for mental health.

Want to learn more about the latest AI developments in mental health? Check the comments for a link to an inspiring story from Google.

What impact do you think AI could have on mental health care accessibility? Let’s discuss!”

Jennifer Bires: Latest AI developments in mental health

Douglas Flora is the Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, overseeing clinical operations, strategic planning, and the expansion of cancer programs. He is also the co-founder of the Center for Precision Medicine; Genomic Health.

As the Editor-in-Chief of ‘AI in Precision Oncology,’ the first peer-reviewed academic journal dedicated to this field, he plays a pivotal role in advancing research. He is also an active board member of the American Cancer Society and ACCC, where he contributes to advocacy, education, and innovation within the cancer community.